Comparing Abilify Maintena vs Latuda
| Abilify Maintena | Latuda |
|
|---|
| Abilify Maintena aripiprazole | Latuda lurasidone |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Bipolar Disorder, Schizophrenia. Abilify Maintena may also be used for purposes not listed in this medication guide. |
Latuda is an atypical antipsychotic used for the treatment of schizophrenia and depression associated with Bipolar 1 disorder. Latuda should be taken with food (at least 350 calories). Prescribed for... View more |
Choose a suggestion below Bipolar Disorder
Schizophrenia
|
|||||||||||||||
| More about Abilify Maintena (aripiprazole) | More about Latuda (lurasidone) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
|||||||||||||||||
| Availability | |||||||||||||||||
|
Prescription only |
Prescription only |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Abilify Maintena has an average rating of 6.1 out of 10 from a total of 49 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 31% reported a negative effect. |
Latuda has an average rating of 6.3 out of 10 from a total of 734 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See the full Abilify Maintena side effects document. |
Common side effects include: psychomotor impairment, akathisia, basal ganglia disease, bradykinesia, cogwheel rigidity, drowsiness, hypokinesia, muscle rigidity, nausea, parkinson's disease, sedated state, tremor, altered serum glucose, and drooling. See the full Latuda side effects document. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Abilify Maintena prices and generic prices |
View all Latuda prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other aripiprazole brands include: Abilify, Abilify MyCite, Aristada, Aristada Initio |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
146 hours |
18 hours |
||||||||||||||||
| CSA Schedule** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 682 drugs are known to interact with Abilify Maintena:
|
A total of 556 drugs are known to interact with Latuda:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
October 28, 2010 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.